| 摘要 |
<p>The present invention is concerned with a solid oral dosage form comprising imatinib, or a pharmaceutically acceptable salt thereof, together with one or more pharmaceutically acceptable excipients, said solid oral dosage form comprising said imatinib in an amount in the range of about 27.0 to 29.0% based on the weight of imatinib free base compared to the total weight of said solid oral dosage form.</p> |
